BioCeriX
ActiveSummary
BioCeriX has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.32M and a net result of €270k. Equity is growing by ~18% per year across the filed fiscal years. Its solvency ranks better than 90% of 8048 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
Checked score
Score 2025
81
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability91▼-9
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.7%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €100k at 30 days acceptable
Liquidity ample (current ratio 12.89 against 19.08 in 2024; short-term debt: 4.8% and cash: 12.4% of total assets), and 11.5% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
88.5%
Return on assets
18.2%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies
more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-03-2026, 127 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
127 d early
2024
55 d early
2023
55 d early
2022
27 d early
2021
24 d early
2020
33 d early
2019
6 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€1.32M▼ 4.3%
2024 · €1.38M
2018: €428k
2019: €471k
2020: €630k
2021: €704k
2022: €831k
2023: €959k
2024: €1.38M
2018 → 2025
Total assets
€1.49M▼ 4.7%
2024 · €1.56M
2018: €607k
2019: €811k
2020: €955k
2021: €985k
2022: €1.09M
2023: €1.47M
2024: €1.56M
2018 → 2025
Net result
€270k▼ 35.2%
2024 · €417k
2018: €35k
2019: €43k
2020: €159k
2021: €73k
2022: €227k
2023: €438k
2024: €417k
2018 → 2025
Working capital
€854k▼ 5.9%
2024 · €908k
2018: €182k
2019: €78k
2020: €218k
2021: €209k
2022: €352k
2023: €478k
2024: €908k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€704k-€831k▲ 18.0%€959k▲ 15.5%€1.38M▲ 43.5%€1.32M▼ 4.3%
Operating result€106k-€68k▼ 35.3%€108k▲ 57.8%€102k▼ 5.8%€118k▲ 16.3%
Net result€73k-€227k▲ 209%€438k▲ 92.9%€417k▼ 4.7%€270k▼ 35.2%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 16% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.49M
Fixed assets
€563k ▼ 6.8%
Current assets
€926k ▼ 3.3%
Equity and liabilities €1.49M
Equity
€1.32M ▼ 4.3%
Debt
€172k ▼ 7.5%
Debt's share of the balance-sheet total falls from 11.9% to 11.5%. Equity and debt are lower.
Key figures and ratios
EBITDA
€162k▲
2024 · €147k
Cash flow
€314k▼
2024 · €463k
Current ratio
12.89▼
2024 · 19.08
Debt to equity
0.13▼
2024 · 0.13
ROE
20.5%▼
2024 · 30.3%
ROA
18.2%▼
2024 · 26.7%
Interest coverage
42.72▲
2024 · 32.38
Debt ≤ 1 year
€72k▲
2024 · €50k
Debt > 1 year
€100k▼
2024 · €135k
Income taxes
€56k▲
2024 · €41k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 49 lines
Balance sheet
Code20242025
Assets
Total assets20/58€1.56M€1.49M▼
Fixed assets21/28€604k€563k▼
Tangible fixed assets22/27€546k€505k▼
Land and buildings22€488k€466k▼
Plant, machinery and equipment23€24k€20k▼
Furniture and vehicles24€34k€18k▼
Financial fixed assets28€58k€58k=
Current assets29/58€958k€926k▼
Amounts receivable within one year40/41€20k€31k▲
Trade receivables40€20k€31k▲
Current investments50/53€696k€705k▲
Cash at bank and in hand54/58€233k€184k▼
Deferred charges and accrued income490/1€9k€6k▼
Equity and liabilities
Total equity and liabilities10/49€1.56M€1.49M▼
Equity10/15€1.38M€1.32M▼
Contributions10/11€19k€19k=
Reserves13€1.36M€1.30M▼
Distributable reserves133€1.36M€1.30M▼
Profit (loss) carried forward14€0€0=
Amounts payable17/49€186k€172k▼
Amounts payable after more than one year17€135k€100k▼
Financial debts170/4€135k€100k▼
Amounts payable within one year42/48€50k€72k▲
Current portion of amounts payable after more than one year42€34k€35k▲
Trade debts44€3k€3k▼
Suppliers440/4€3k€3k▼
Taxes, remuneration and social security45€10k€32k▲
Taxes450/3€10k€29k▲
Remuneration and social security454/9-€3k
Other amounts payable47/48€3k€2k▼
Accrued charges and deferred income492/3€848€227▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€45k€44k▼
Other operating charges640/8€5k€5k▲
Gross operating margin9900€152k€167k▲
Operating profit (loss)9901€102k€118k▲
Financial income75/76B€361k€212k▼
Recurring financial income75€361k€212k▼
Financial charges65/66B€5k€4k▼
Recurring financial charges65€5k€4k▼
Profit (loss) for the period before taxes9903€458k€327k▼
Income taxes67/77€41k€56k▲
Profit (loss) for the period9904€417k€270k▼
Profit (loss) for the period to be appropriated9905€417k€270k▼
Appropriation of the result
Profit (loss) to be appropriated9906€417k€270k▼
Transfer from equity791/2€0€329k▲
Transfer to equity691/2€417k€270k▼
To other reserves6921€417k€270k▼
Profit to be distributed694/7€0€329k▲
Return on contributions (dividend)694€0€329k▲
The notes to these accounts (19 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
26-03
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
06-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Liquidity times 8current ratio 19.08
Current ratio from 2.42 to 19.08; short-term debt falls from €338k to €50k.
31-12
Financial
Equity above €1MEq €1.38M ▲43.5%
7 profitable years in a row build equity to €1.38M.
06-06
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial
Highest result since 2018net €438k ▲92.9%
Net result €438k, the highest in the series.
04-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
07-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
28-06
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial
Equity above €500kEq €630k ▲33.7%
3 profitable years in a row build equity to €630k.
06-08
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 6 days late
2019
03-06
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
18-06
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
25-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 25 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Rumst · 3 establishment units since 2008
Ground area
3.2 ha
Building footprint
1,035 m²
Volume, LiDAR
5,502 m³
3 parcels, Flanders · tallest building 10.5 m, ±3 floors. Linked by address, not a title deed.
3 establishment units
BioCeriX
since 20082.174.757.519
Scherpenhoek 10, 2850 Boom
since 20152.276.612.170
Noeveren 56+, 2850 Boom
since 20192.291.949.355
3 parcels
Flanders
3
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11005A0549/00Z000 | Flanders | 2.2 ha | 1 · 91 m² | 10.5 m · 3 fl. |
| 11005A0384/00M004 | Flanders | 8,458 m² | 1 · 712 m² | 7.1 m · 2 fl. |
| 11037A0240/00H000 | Flanders | 2,460 m² | 1 · 231 m² | 10.2 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 2
3 of 3 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage (source: regional heritage registers, Onroerend Erfgoed / patrimoine.brussels).
Similar companies · same sector, comparable size
V.I.P. SRL
BE 0451.006.943
Fleurus · Eq €1.34M
Server Storage Solutions
BE 0824.318.668
Nazareth-De Pinte · Eq €1.29M
Abus Belgium
BE 0652.893.538
Hasselt · Eq €1.26M
Gedeon Richter Benelux
BE 0844.129.731
Dilbeek · Eq €1.23M
IDEFA
BE 0478.682.528
Hasselt · Eq €1.22M
Of 1,744 companies in sector 46150 we hold annual accounts for 759. 328 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded20-11-2008
Fiscal year end31-12
Activities, NACEBEL 2025
46150Agents in the wholesale of furniture, household goods and hardware
21209Manufacture of basic pharmaceutical products and pharmaceutical preparations
46460Wholesale of pharmaceutical and medical goods
63920Other information service activities
73200Market research and public opinion polling
85599Other education
Sources
Crossroads Bank for EnterprisesNational Bank · 17 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryE-mail:kris@biocerix.com